ADVERTISEMENT
Africanian
  • News
  • News 24/7
  • Politics
  • Business
  • Health
  • Sports
  • Travel
  • World
    • US
    • Russia
    • Europe
    • Asia
    • America
No Result
View All Result
Africanian
No Result
View All Result
Home Health

A New Study On Children With HIV, Reveals Success On Alternative Low Cost Easy Treatment

A new study has revealed that a once-a-day antiretroviral medicine that is low-cost and easy for children to take is more effective at suppressing HIV than standard treatments.

in Health, News
Reading Time: 2 mins read
0 0
0
A New Study On Children With HIV, Reveals Success On Alternative Low Cost Easy Treatment
0
SHARES
Share on FacebookShare on TwitterShare via Whatsapp

By Metohuey Michael Adoglo

The global study led by researchers at University College London and published in The New England Journal of Medicine found that dolutegravir-based regimens, which are already widely used to treat adults, reduced the chances of treatment failure among young people aged three to 18 by around 40 per cent compared to standard treatments.

As reported by EurekAlert, the findings were based on a randomised controlled trial called ODYSSEY involving more than 700 children from 29 clinical centres in Africa, Europe, and Asia, who were randomly given either dolutegravir or standard anti-HIV drugs, and who were followed up for at least two years.

The findings from the trial, which was sponsored by the Penta Foundation and funded by ViiV Healthcare, informed new guidance by the World Health Organisation, recommending the use of dolutegravir-based treatment for children.

In the study, researchers found that 14% of children receiving dolutegravir experienced treatment failure over two years compared to 22% of children receiving standard treatment.

More

Top 5 Reasons to be Optimistic About AI Development in Africa

Top 10 Jobs AI Will Take Over in the Next Decade in Africa

Benin: Petrol Prices Soar as Nigeria Moves to End Subsidy

Evidence from adults shows dolutegravir has a high genetic barrier to resistance, meaning viruses are less likely to become resistant to it over time. This was replicated in the ODYSSEY trial, with much less resistance occurring among children and adolescents on dolutegravir-based treatment.

Past studies have suggested dolutegravir may be associated with weight gain among adults but the researchers said the new findings were reassuring for children, with those given dolutegravir gaining 1kg more and growing 1cm higher over two years – both indicating better growth rather than abnormal weight gain. Children in the dolutegravir arm had better lipid profiles, meaning a lower risk of cardiovascular disease in the long term.

The trial participants were enrolled in Uganda, Zimbabwe, South Africa, Thailand, the UK, Spain, Portugal, and Germany. Most of the participants were based in sub-Saharan Africa, where most children living with HIV are.

The opinion of the author don’t necessarily reflect those of Africanian News.

africanian

africanian

Africanian, an Africa news media portal.

  • Trending
  • Comments
  • Latest
China-Africa Relations: the continent's finest in the Middle Kingdom

China-Africa Relations: the continent’s finest in the Middle Kingdom

May 27, 2023
Sino-African Relations: Eventful Ceremony brings to a close Think Tank Forum

Sino-African Relations: Eventful Ceremony brings to a close Think Tank Forum

June 4, 2023
Promoting Gender Equality in African Technology Hubs

Promoting Gender Equality in African Technology Hubs

May 29, 2023
Top 5 Reasons to be Optimistic About AI Development in Africa

Top 5 Reasons to be Optimistic About AI Development in Africa

June 5, 2023
Top 10 Jobs AI Will Take Over in the Next Decade in Africa

Top 10 Jobs AI Will Take Over in the Next Decade in Africa

June 5, 2023
Benin: Petrol Prices Soar as Nigeria Moves to End Subsidy

Benin: Petrol Prices Soar as Nigeria Moves to End Subsidy

June 4, 2023
Africanian

Copyright © 2022 Africanian.com.

Follow Us

No Result
View All Result
  • News
  • Politics
  • Business
  • Health
  • Sports
  • Entertainment
  • Tech
  • Travel
  • World

Copyright © 2022 Africanian.com.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Log In

Sign In

Forgot password?

Don't have an account? Register

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.